SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000947871-20-000465
Filing Date
2020-05-14
Accepted
2020-05-14 17:25:07
Documents
2
Group Members
ORBIMED ISRAEL GP LTD

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D ss173646_sc13d.htm SC 13D 82496
2 JOINT FILING AGREEMENT ss173646_ex9901.htm EX-99.1 5402
  Complete submission text file 0000947871-20-000465.txt   89734
Mailing Address 8480 HONEYCUTT ROAD SUITE 120 RALEIGH NC 27615
Business Address 8480 HONEYCUTT ROAD SUITE 120 RALEIGH NC 27615 919-275-1933
9 METERS BIOPHARMA, INC. (Subject) CIK: 0001551986 (see all company filings)

IRS No.: 273948465 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90111 | Film No.: 20879139
SIC: 2834 Pharmaceutical Preparations

Mailing Address 601 LEXINGTON AVENUE, 54TH FLOOR NEW YORK NY 1022-4629
Business Address 89 MEDINAT HAYEHUDIM STREET, 11TH FLOOR HERZLIYA L3 46766 212-739-6400
OrbiMed Israel BioFund GP Limited Partnership (Filed by) CIK: 0001569821 (see all company filings)

IRS No.: 980697985 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13D